Atea Pharmaceuticals
AVIR
AVIR
102 hedge funds and large institutions have $1.26B invested in Atea Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 41 increasing their positions, 17 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
21% less call options, than puts
Call options by funds: $3.75M | Put options by funds: $4.77M
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
58% less capital invested
Capital invested by funds: $3.04B → $1.26B (-$1.78B)
Holders
102
Holding in Top 10
5
Calls
$3.75M
Puts
$4.77M
Top Buyers
| 1 | +$73.7M | |
| 2 | +$51.9M | |
| 3 | +$35.5M | |
| 4 |
AICPI
ABG Innovation Capital Partners III
Central, Hong Kong,
Hong Kong
|
+$27.2M |
| 5 |
Morgan Stanley
New York
|
+$15.7M |
Top Sellers
| 1 | -$52.3M | |
| 2 | -$19.8M | |
| 3 | -$19.4M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$18.7M |
| 5 |
PA
Perceptive Advisors
New York
|
-$18.3M |